Hsia TC

No ORCID on file · 9 papers in corpus
observational 2026
In vivo (Athens, Greece) ·doi:10.21873/invivo.14347

BACKGROUND/AIM: Pterygium is a common ocular surface disorder with multifactorial etiology involving environmental exposure and immune dysregulation. Interleukin-12 (IL-12), a key immunomodulatory cytokine, has been implicated in inflammati…

observational 2026
In vivo (Athens, Greece) ·doi:10.21873/invivo.14422

BACKGROUND/AIM: Pterygium is a common ocular surface disorder associated with long-term ultraviolet exposure and/or oxidative DNA damage. Accumulated evidence suggests that defects in DNA repair pathways may contribute to pterygium risk. DN…

observational 2026
Cancer genomics & proteomics ·doi:10.21873/cgp.20573

BACKGROUND/AIM: Pterygium is a fibrovascular ocular disease characterized by extracellular matrix (ECM) remodeling. Matrix metalloproteinase-3 (MMP-3), a key ECM-modulating enzyme, has been implicated to involved in pterygium progression, b…

observational 2025
Anticancer research ·doi:10.21873/anticanres.17436

BACKGROUND/AIM: Over-expression of matrix metalloproteinase-1 (MMP-1) has been suggested as a biomarker for endometriosis. However, the genetic influence of MMP-1 in the pathogenesis of endometriosis remains unclear, with its role yet to be…

observational 2025
In vivo (Athens, Greece) ·doi:10.21873/invivo.14116

BACKGROUND/AIM: Pterygium is a common ocular surface disorder characterized by abnormal fibrovascular growth and extracellular matrix remodeling, yet its precise molecular etiology remains unclear. Matrix metalloproteinases (MMPs) have been…

observational 2024
In vivo (Athens, Greece) ·doi:10.21873/invivo.13472

BACKGROUND/AIM: In the literature, the studies about the role of matrix metalloproteinase-2 (MMP-2) in pterygium diagnosis are mainly based on its protein expression. The role of MMP-2 variants has never been examined. The aim of this study…

observational 2022
In vivo (Athens, Greece) ·doi:10.21873/invivo.13002

BACKGROUND/AIM: The over-expression of enhancer of zeste homolog 2 (EZH2) protein is found in oral cancer tissues. However, the genetic role of the enhancer of EZH2 in the etiology of oral cancer is unknown. The aim of this study was to eva…

observational 2022
Anticancer research ·doi:10.21873/anticanres.15933

BACKGROUND/AIM: Flap endonuclease 1 (FEN1) is a critical protein in DNA repair, genomic stability, and carcinogenesis. Functional polymorphisms in FEN1 promoter -69G>A (rs174538) and 3'UTR 4150G>T (rs4246215), have been associated with the …

observational 2017
Oncotarget ·doi:10.18632/oncotarget.16520

The association of uterine leiomyoma with increased risk of breast cancer is controversial. Therefore, we used the National Health Insurance Research Database of Taiwan to examine breast cancer incidence and mortality among Asian patients w…